Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Mainstay Medical International
  6. Summary
    MSTY   IE00BJYS1G50

MAINSTAY MEDICAL INTERNATIONAL

(MSTY)
 SummaryNewsRatingsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2019 1,11 M - -
Net income 2019 -22,4 M - -
Net Debt 2019 0,34 M - -
P/E ratio 2019 -1,63x
Yield 2019 -
Sales 2020 1,50 M - -
Net income 2020 -18,9 M - -
Net Debt 2020 17,8 M - -
P/E ratio 2020 -1,39x
Yield 2020 -
Capitalization 29,7 M 29,8 M -
EV / Sales 2019 46,6x
EV / Sales 2020 31,7x
Nbr of Employees 40
Free-Float 63,9%
More Financials
Company
Mainstay Medical International plc is a medical device company. The Company is focused on the development and commercialization of ReActiv8. The Company operates through Active Implantable Medical Devices (AIMDs) segment. The Company's ReActiv8 is an implantable neurostimulation system to treat disabling chronic low back pain (CLBP). ReActiv8 is designed to electrically stimulate the nerves responsible for... 
More about the company
All news about MAINSTAY MEDICAL INTERNATIONAL
07/09Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December..
CI
06/29Mainstay Medical Announces Limited Announces Commercial Launch of ReActiv8« in US
CI
04/20Oxford Finance LLC Announces Closing of $50 Million Senior Secured Term Loan with Mains..
CI
03/08Mainstay Medical Announces Commercial Launch of ReActiv8« in Australia
CI
02/16Mainstay Medical Holdings plc announced that it has received $108 million in funding fr..
CI
02/09Mainstay Medical Holdings plc announced a financing transaction
CI
2020Mainstay Medical Holdings plc Announces U.S. FDA Approval of ReActiv8« Neurostimulation..
CI
2020MAINSTAY MEDICAL : announces Scheme becoming effective
BU
2020MAINSTAY MEDICAL : áReceipt of High Court Approval in Connection With Proposed Reorganisat..
BU
2020MAINSTAY MEDICAL INTERNATIONAL : Announces Expected Timetable for Completion of Reorganisa..
BU
2020MAINSTAY MEDICAL INTERNATIONAL : Monthly statement on outstanding equity shares and voting..
CO
2020MAINSTAY MEDICAL INTERNATIONAL : Announces Date for Court Hearing
BU
2020MAINSTAY MEDICAL INTERNATIONAL : Announces Results of Scheme Meeting and EGM
BU
2020MAINSTAY MEDICAL : Announces Publication and Posting of Circular Related to Proposed Reorg..
BU
2020MAINSTAY MEDICAL INTERNATIONAL : Announces Strategic Plans to Maximize Shareholder Value, ..
BU
More news
News in other languages on MAINSTAY MEDICAL INTERNATIONAL
2020MAINSTAY MEDICAL : annonce l'entrée en vigueur du Concordat
2020MAINSTAY MEDICAL : áHomologation du tribunal en vue du projet de réorganisation
2020MAINSTAY MEDICAL INTERNATIONAL : annonce le calendrier probable de sa réorganisation
2020MAINSTAY MEDICAL INTERNATIONAL : annonce la date de l'audience
2020MAINSTAY MEDICAL INTERNATIONAL : annonce le résultat des votes de l'Assemblée de concordat..
More news
Income Statement Evolution
Managers and Directors
Jason M. Hannon Chief Executive Officer & Executive Director
Matthew W. Onaitis Chief Financial Officer & Secretary
Oern Reidar Stuge Independent Non-Executive Chairman
Diane Burnside Vice President-Clinical Affairs
Jan Pieter Heemels VP-Clinical & Scientific Communication
Sector and Competitors